India's medical device industry is voicing fresh concerns over the sharp rise in low-cost imports, particularly from ASEAN countries, as manufacturers warn that aggressive pricing is making it increasingly difficult for domestic companies to compete despite expanding local production capacity. The discussion has gained momentum following the launch of an anti-dumping investigation into dialyser imports from China and Malaysia. Industry stakeholders believe the probe could have broader implications for India's medical device manufacturing ecosystem, especially in product categories where domestic capabilities have strengthened over the past few years.
According to industry data, medical device imports from ASEAN countries increased by about 14% in FY25-26, reaching nearly Rs 13,000 crore. The growth has been driven by products such as syringes, surgical gloves, dialysis consumables, and…
